Get the Stockscreener App
91.30
1.06%
0.8301
Globus Medical Inc stock is traded at $91.30, with a volume of 42,539.
It is up +1.06% in the last 24 hours and up +0.36% over the past month.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
See More
Previous Close:
$90.47
Open:
$90.88
24h Volume:
42,539
Relative Volume:
0.03
Market Cap:
$12.22B
Revenue:
$2.51B
Net Income/Loss:
$185.56M
P/E Ratio:
68.13
EPS:
1.34
Net Cash Flow:
$517.59M
1W Performance:
+4.00%
1M Performance:
+0.36%
6M Performance:
+54.51%
1Y Performance:
+8.93%
1-Day Range:
$90.71
$91.45
1-Week Range:
$85.65
$91.45
52-Week Range:
$51.79
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Name
Globus Medical Inc
Sector
Industry
Phone
610-930-1800
Address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
91.33 | 12.11B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
128.85 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.69 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
357.50 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.06 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.07 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-25 | Upgrade | Truist | Hold → Buy |
| Oct-28-25 | Resumed | Stifel | Hold |
| May-27-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-10-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-07-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-20-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Mar-18-24 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-19-23 | Upgrade | Stifel | Hold → Buy |
| Mar-30-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-13-23 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-23 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-10-23 | Downgrade | Loop Capital | Buy → Hold |
| Feb-10-23 | Downgrade | Needham | Buy → Hold |
| Feb-10-23 | Downgrade | Truist | Buy → Hold |
| Feb-10-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-28-22 | Initiated | Wells Fargo | Overweight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-13-21 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-29-21 | Initiated | Loop Capital | Buy |
| Feb-18-21 | Resumed | Needham | Buy |
| Dec-08-20 | Initiated | Citigroup | Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Aug-06-20 | Reiterated | Needham | Buy |
| Aug-06-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jul-21-20 | Initiated | Northland Capital | Market Perform |
| Jul-06-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-08-20 | Reiterated | Needham | Buy |
| Mar-18-20 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-12-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Aug-02-19 | Reiterated | Needham | Buy |
| May-24-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| May-03-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Upgrade | UBS | Neutral → Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-27-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| May-03-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Upgrade | Needham | Hold → Buy |
View All
Globus Medical Inc Stock (GMED) Latest News
Does Globus Medical (NYSE:GMED) Deserve A Spot On Your Watchlist? - Yahoo Finance
Allspring Global Investments Holdings LLC Acquires 312,149 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (NYSE:GMED) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Globus Medical Inc: The Spine Stock Wall Street Slept On (Until Now) - AD HOC NEWS
Globus Medical (GMED) Lags Q1 Earnings and Revenue Estimates - sharewise.com
The Truth About Globus Medical Inc: Why Wall Street Suddenly Can’t Ignore It - AD HOC NEWS
Fort Washington Investment Advisors Inc. OH Raises Holdings in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (NYSE:GMED) Listed in NYSE Composite Healthcare Group - Kalkine Media
Should I hold or sell Globus Medical Inc. stock in 2025Debt-to-Equity Ratio Analysis & Free High Yield Investment Strategies - bollywoodhelpline.com
Globus Medical, Inc. $GMED is Paradice Investment Management LLC's Largest Position - MarketBeat
BTIG reiterates Neutral rating on Globus Medical stock after strong Q3 - Investing.com Canada
Audubon’s Globus Medical Makes Game-Changing Acquisition - MSN
Boston Trust Walden Corp Takes $67.89 Million Position in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Globus Medical, Inc. Class A Common Stock (NYSE:GMED) Stock Quote - FinancialContent
Swedbank AB Increases Position in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED): Assessing Valuation After a 60% Three-Month Share Price Surge - Sahm
Globus Medical (STU:GM0N) EV-to-OCF : 15.30 (As of Dec. 24, 2025) - GuruFocus
Globus Medical Earnings Notes - Trefis
Here's Why Globus Medical (GMED) is a Strong Growth Stock - sharewise.com
Exchange Traded Concepts LLC Has $13.41 Million Stake in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED) Stock Trades Up, Here Is Why - Finviz
Globus Medical (GMED) Gains as Analysts Raise Price Targets in Late 2025News and Statistics - IndexBox
Profit Investment Management LLC Has $1.09 Million Holdings in Globus Medical, Inc. $GMED - MarketBeat
Why Globus Medical (GMED) is a top growth stock for the long term - MSN
How Investors May Respond To Globus Medical (GMED) Analyst Optimism Around Clinical Trial Momentum - Sahm
Is Globus Medical Inc. Class stock undervalued historicallyEarnings Risk Report & Growth Focused Entry Reports - ulpravda.ru
Precision Trading with Globus Medical Inc. Class A (GMED) Risk Zones - Stock Traders Daily
Will Globus Medical Inc. stock attract ESG investors2025 Momentum Check & Free Long-Term Investment Growth Plans - ulpravda.ru
Will Globus Medical Inc. stock benefit from upcoming earnings reportsMarket Sentiment Report & Precise Trade Entry Recommendations - ulpravda.ru
Can Globus Medical Inc. stock continue upward trend2025 Key Lessons & Smart Money Movement Alerts - DonanımHaber
Is Globus Medical Still Attractive After Recent Gains and DCF Implied Upside? - Yahoo Finance
Why Globus Medical Inc. stock could benefit from AI revolutionTrade Performance Summary & Step-by-Step Trade Execution Guides - DonanımHaber
Globus Medical (GMED): Reassessing Valuation After a 55% Three-Month Share Price Surge - Yahoo Finance
Is Globus Medical Inc. stock dividend yield sustainablePortfolio Performance Report & Accurate Entry and Exit Point Alerts - DonanımHaber
What is the fair value of Globus Medical Inc. stock nowBear Alert & Free Reliable Trade Execution Plans - Улправда
Globus Medical (GMED) Stock Up on RBC Target Boost & Trial NewsNews and Statistics - IndexBox
Analysts Offer Insights on Healthcare Companies: Novan (NOVN) and Globus Medical (GMED) - The Globe and Mail
RBC Capital Maintains Globus Medical (GMED) Outperform Recommendation - Nasdaq
Freedom Capital Markets Initiates Coverage of Globus Medical (GMED) with Hold Recommendation - Nasdaq
Canaccord Genuity Maintains Globus Medical (GMED) Buy Recommendation - Nasdaq
GMED Stock: Analyst Raises Price Target to $105, Maintains Buy R - GuruFocus
Analyst Upgrade: How buybacks impact Globus Medical Inc stock value2025 Volume Leaders & AI Powered Market Trend Analysis - moha.gov.vn
RBC Adjusts Price Target on Globus Medical to $100 From $92, Maintains Outperform Rating - marketscreener.com
RBC Capital Raises Price Target for GMED to $100, Maintains Outp - GuruFocus
Pedicle Screw Systems Market Size to Hit USD 3.71 Billion by 2033, Growing at a CAGR of 5.76% - GlobeNewswire Inc.
Thrivent Financial for Lutherans Reduces Holdings in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Director Sells 4,000 Shares - TradingView — Track All Markets
Dir Norwalk Sells 4,000 ($355.4K) Of Globus Medical Inc [GMED] - TradingView — Track All Markets
Globus Medical (NYSE: GMED) director reports 4,000-share sale at $88.85 - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Globus Medical Inc Stock (GMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):